Related Experiment Video
Updated: Jan 15, 2026

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
TLRs/PI3K/AKT1B Signaling Pathway Is Involved in Modulation of Neuroinflammation in the Rat Hippocampus by
Shamseddin Ahmadi1, Hawsar Rashid Ahmed2, Bestan Yousif Abdullah3
1Department of Biological Science, Faculty of Science, University of Kurdistan, P.O. Box 416, Sanandaj, Iran. sh.ahmadi@uok.ac.ir.
Abstract:
Toll-like receptors (TLRs) in the brain significantly contribute to various central nervous system (CNS) disorders, including addiction. Morphine's interaction with TLR4 contributes to dependence and withdrawal. Alpha-pinene, a monoterpene with anti-inflammatory properties, has not been studied for its effects on TLR signaling in morphine dependence and withdrawal. This study investigated alpha-pinene's impact on hippocampal TLR pathways in morphine-dependent and withdrawing rats. Male Wistar rats were divided into two categories: dependence and withdrawal. The three dependence groups received saline + dimethyl sulfoxide 5% (DMSO), morphine (10 mg/kg) + DMSO, or morphine + alpha-pinene (20 mg/kg) for 10 days. The three withdrawal groups received the same saline or morphine treatments as the dependent groups for ten days. Following this, they went through a 30-day morphine washout phase with daily DMSO (the first and second groups) or alpha-pinene (the third group) administration. Rats in all groups were sacrificed either on day 10 (after repeated injections) or 30 days post-withdrawal. Hippocampal tissues were then dissected and analyzed via Western blot and ELISA to assess protein level changes. Results showed increased hippocampal expression of TLR2, TLR4, TLR10, and MyD88 following morphine dependence and withdrawal, while levels of PI3K, p-AKT1B, and IL-1Ra decreased. Alpha-pinene treatment, whether administered during the 10-days dependence induction period or the 30-days withdrawal period, partially restored these alterations in the TLR pathway. These findings suggest alpha-pinene modulates central immune responses by regulating TLR signaling. This highlights therapeutic potential of alpha-pinene for controlling neuroinflammation and subsequent morphine-related complications like tolerance, addiction, and withdrawal.
Insights
Alpha-pinene may help manage morphine dependence and withdrawal by regulating brain immune responses. This study shows alpha-pinene impacts toll-like receptor (TLR) pathways involved in morphine addiction and withdrawal symptoms.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Toll-like receptors (TLRs) in the brain are implicated in central nervous system disorders, including addiction.
- Morphine dependence and withdrawal involve TLR4 signaling, but the effects of anti-inflammatory compounds like alpha-pinene on these pathways remain unexplored.
Purpose of the Study:
- To investigate the impact of alpha-pinene on hippocampal toll-like receptor (TLR) pathways in rats experiencing morphine dependence and withdrawal.
Main Methods:
- Male Wistar rats were subjected to morphine dependence induction or withdrawal protocols.
- Alpha-pinene (20 mg/kg) or DMSO was administered during dependence (10 days) or withdrawal (30 days post-morphine).
- Hippocampal tissues were analyzed using Western blot and ELISA to measure protein levels of TLRs, MyD88, PI3K, p-AKT1B, and IL-1Ra.
Main Results:
- Morphine dependence and withdrawal increased hippocampal TLR2, TLR4, TLR10, and MyD88 expression while decreasing PI3K, p-AKT1B, and IL-1Ra.
- Alpha-pinene administration, during either dependence or withdrawal, partially reversed these changes in the TLR pathway.
Conclusions:
- Alpha-pinene modulates central immune responses by regulating TLR signaling pathways in the brain.
- These findings suggest alpha-pinene has therapeutic potential for managing neuroinflammation and morphine-related complications such as tolerance, addiction, and withdrawal.
More Related Videos
08:16Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
Published on: October 6, 2022
16:13Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro
Published on: June 13, 2011